Journal Reviews

European Urology journal cover image

One cycle of adjuvant chemotherapy in tumours of the testis

4 May 2020 | | Urologic Oncology | Adjuvant therapy, BEP, Chemotherapy, NSGCTT, Phase III trial, Surveillance, Testicular cancer

Following a radical orchiectomy, current UK practice for newly diagnosed, high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis (NSCGCTT) is either two cycles of adjuvant chemotherapy with bleomycin, etoposide, cisplatin (BE360Px2) or surveillance with BE500Px3 on...